United Kingdom research governance strategy.

the UK. London: King’s Fund, 2002. 3 Department of Health. Research and development for a first class service. London: DoH, 2000. www.doh.gov.uk/research/documents/rd3/ first_class_service.pdf (accessed 3 July 2003). 4 Department of Health website. www.doh.gov.uk/research/ (accessed 3 July 2003). 5 Culyer A. Supporting research and development in the NHS. Report of the Department of Health Research and Development Task Force. London: HMSO, 1994. 6 Arnold E,Morrow S, Thuriaux B,Martin B. Implementing the Culyer reforms in North Thames: final report. science and technology policy research. London: Technopolis, 1999. 7 Harrison A, New B. The finance of research and development in health care. Health Care UK 2001: the King’s Fund review of health policy.London: King’s Fund, 2001: 26-44. 8 McCollum C. UK National Health Service R&D funding—a bureaucratic nightmare. Lancet 2003;361:1906. 9 Pharmaceutical Industry Competitiveness Taskforce. Final report. London: DoH, 2001. 10 Pharmaceutical Industry Competitiveness Taskforce. Clinical research report. London: DoH, 2002. 11 Department of Health.NHS Cancer Plan. London: DoH, 2000. 12 National Cancer Research Institute. Strategic analysis 2002. London: NCRI, 2002. http://www.ncri.org.uk/documents/publications/ reportdocs/NCRI_Strategic_Analysis_2002.pdf (accessed 2 July 2003). 13 National Cancer Tissue Resource. www.ntrac.org.uk/Initiatives/NCTR/ NCTR.asp (accessed 8 July 2003). 14 Office of Science and Technology. Public sector research exploitation fund—basic guidelines. www.ost.gov.uk/enterprise/knowledge/ psrefundguide.pdf (accessed 5 August 2003). 15 Department of Health. Science and innovation strategy. London: DoH, 2001. 16 Department of Health. The NHS as an innovative organisation: a framework and guidance on the management of intellectual property in the NHS. London: DoH, 2002. 17 Department of Health. NHS R&D funding consultation paper: NHS support for science. London: DoH, 2000. 18 Department of Health. NHS R&D funding consultation paper: NHS priorities and needs funding. London: DoH, 2000. 19 Department of Health. NHS priorities and needs R&D funding: a position paper. London: DoH, 2001. 20 Kerrison S, McNally N, Pollock AM. United Kingdom research governance strategy. BMJ 2003;327:553-6. 21 Walt G, Brugha R, Haines AWorking with the private sector: the need for institutional guidelines BMJ 2002;325:432-5. 22 Korn D. Conflicts of interest in biomedical research. JAMA 2000;284:2234-8. 23 Morin K, Rakatansky H, Riddick FA Jr, Morse LJ, O’Bannon JM 3rd, Goldrich MS, et al. Managing conflicts of interest in the conduct of clinical trials JAMA 2002;287:78-84. (Accepted 3 June 2003)